Cargando…
COVID-19 pneumonia: do not leave the corticosteroids behind!
The host inflammatory response is critical in the progression of lung injuries in patients with SARS-CoV-2. Corticosteroids (CS) have been widely used as immunomodulating agents, but the right timing, dosage and type of molecule are unknown. In fact, the early use of CS could facilitate the viral re...
Autores principales: | Pinna, Simone Mornese, Scabini, Silvia, Corcione, Silvia, Lupia, Tommaso, De Rosa, Francesco G |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Future Medicine Ltd
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7958644/ https://www.ncbi.nlm.nih.gov/pubmed/33709775 http://dx.doi.org/10.2217/fmb-2020-0199 |
Ejemplares similares
-
New cephalosporins for the treatment of pneumonia in internal medicine wards
por: Lupia, Tommaso, et al.
Publicado: (2020) -
2019 novel coronavirus (2019-nCoV) outbreak: A new challenge
por: Lupia, Tommaso, et al.
Publicado: (2020) -
Predictors of mortality in patients with COVID-19 infection in different health-care settings: A retrospective analysis from a CORACLE study group
por: Boglione, Lucio, et al.
Publicado: (2023) -
Monoclonal antibodies for the treatment of COVID-19 patients: An umbrella to overcome the storm?
por: Mornese Pinna, Simone, et al.
Publicado: (2021) -
The Diagnostic Relevance of β-D-Glucan for Candidemia within Internal Medicine Wards
por: Corcione, Silvia, et al.
Publicado: (2022)